Tag Archives: MMV

MMV@20: Leaders say innovative tools still needed to conquer malaria

The war against malaria will not be won without increased innovation for new, transformative tools, Dr David Reddy, CEO, Medicines for Malaria Venture (MMV) has said. Speaking while marking the 20th Anniversary of the MMV, Dr Davd noted that those last 20 years have offered this war vital lessons. “Today is a chance for us

Novartis, Medicines for Malaria Venture launch a novel compound against multidrug-resistant malaria

Ahead of the World Malaria Day, Novartis and Medicines for Malaria Venture (MMV) have launched a patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite. The trial will test the efficacy of KAF156 in combination with a new, improved formulation of the existing antimalarial lumefantrine.

Top